• Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from Analysts at HC Wainwright

    Source: Buzz FX / 10 Jan 2025 09:04:14   America/New_York


    Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from Analysts at HC Wainwright Written by MarketBeat January 10, 2025 Share Link copied to clipboard. Research analysts at HC Wainwright started coverage on shares of Bright Minds Bios
    Read more...
Share on,